[go: up one dir, main page]

HRP20170793T1 - Uporaba kombiniranih pripravaka koji obuhvaćaju antimikotike - Google Patents

Uporaba kombiniranih pripravaka koji obuhvaćaju antimikotike Download PDF

Info

Publication number
HRP20170793T1
HRP20170793T1 HRP20170793TT HRP20170793T HRP20170793T1 HR P20170793 T1 HRP20170793 T1 HR P20170793T1 HR P20170793T T HRP20170793T T HR P20170793TT HR P20170793 T HRP20170793 T HR P20170793T HR P20170793 T1 HRP20170793 T1 HR P20170793T1
Authority
HR
Croatia
Prior art keywords
drug
combined
vaginal
cox1
nsaid
Prior art date
Application number
HRP20170793TT
Other languages
English (en)
Inventor
Christian Noe
Marion Noe-Letschnig
Original Assignee
Christian Noe
Marion Noe-Letschnig
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christian Noe, Marion Noe-Letschnig filed Critical Christian Noe
Publication of HRP20170793T1 publication Critical patent/HRP20170793T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Claims (2)

1. Kombinirani lijek, naznačen time, da obuhvaća sljedeće: - antimikotičko sredstvo, pri čemu je navedeno antimikotičko sredstvo klotrimazol ili mikonazol, i - nesteroidni protuupalni lijek (NSAID) koji ima dovoljno COX1-inhibicije, definiran putem izdvajanja spojeva koji imaju omjer COX1/COX2 (IC50, microM) veći od 20, pri čemu navedeni NSAID je diklofenak ili mefenaminska kiselina, dok je lijek za uporabu u topikalnom liječenju Candida-mikoza koje su odabrane od sljedećih: vulvovaginalne kandidaze, orofaringealne kandidaze (afte u usnoj šupljini), pelenski dermatitis (pelenski osip), intertriginozni ekcem, pri čemu se navedeni kombinirani lijek pripravlja kao mast, krema, vaginalni supozitorij, vaginalna tableta, oralna tableta ili tableta za pod jezik, prašak ili aerosol.
2. Kombinirani lijek za uporabu prema zahtjevu 1, naznačen time, da se navedeni kombinirani lijek dostavlja na inertnom nosaču, posebno na vaginalnom prstenu, na dijafragmi ili na tamponu.
HRP20170793TT 2006-05-12 2007-05-10 Uporaba kombiniranih pripravaka koji obuhvaćaju antimikotike HRP20170793T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT8262006 2006-05-12
PCT/AT2007/000227 WO2007131253A2 (de) 2006-05-12 2007-05-10 Verwendung von kombinationspräparaten, umfassend antimykotika
EP07718439.8A EP2018164B1 (de) 2006-05-12 2007-05-10 Verwendung von kombinationspräparaten, umfassend antimykotika

Publications (1)

Publication Number Publication Date
HRP20170793T1 true HRP20170793T1 (hr) 2017-10-06

Family

ID=37903545

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20170793TT HRP20170793T1 (hr) 2006-05-12 2007-05-10 Uporaba kombiniranih pripravaka koji obuhvaćaju antimikotike

Country Status (19)

Country Link
US (2) US8552042B2 (hr)
EP (2) EP2018164B1 (hr)
JP (1) JP2009536926A (hr)
CN (1) CN101484162A (hr)
AU (1) AU2007250502B2 (hr)
CA (1) CA2651726C (hr)
CY (1) CY1119094T1 (hr)
DK (1) DK2018164T3 (hr)
ES (1) ES2627268T3 (hr)
HR (1) HRP20170793T1 (hr)
HU (1) HUE033499T2 (hr)
LT (1) LT2018164T (hr)
NO (2) NO342103B1 (hr)
PL (1) PL2018164T3 (hr)
PT (1) PT2018164T (hr)
RS (1) RS56044B1 (hr)
RU (1) RU2008148977A (hr)
SI (1) SI2018164T1 (hr)
WO (1) WO2007131253A2 (hr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI23311A (sl) * 2010-03-19 2011-09-30 Kemijski inštitut Farmacevtska kombinacija acetilsalicilne kisline in protiglivne substance za uničevanje ali inhibicijo rasti in replikacije gliv
CN102210649A (zh) * 2010-04-09 2011-10-12 上海医药科技发展有限公司 一种两性霉素b乳膏及其制备方法
FR2993179B1 (fr) * 2012-07-13 2016-01-08 Lesaffre & Cie Levure saccharomyces cerevisiae pour prevenir et/ou traiter les mycoses vaginales
CN103044408A (zh) * 2013-01-21 2013-04-17 万礼 在治疗恶性肿瘤时应用的伊曲康唑或其盐及其组合物
US8883747B1 (en) * 2013-10-09 2014-11-11 Craig W. Carver Topical antifungal compositions and methods of use thereof
HK1246146A1 (zh) * 2015-01-13 2018-09-07 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. 用於治療真菌病的藥物組合物
CN104920360B (zh) * 2015-06-18 2017-04-12 青岛农业大学 丁苯羟酸在制备用于防治由植物病原菌引起的植物病害的杀菌剂中的用途
MX2020005055A (es) * 2017-11-14 2020-10-28 Profem Gmbh Emulsiones para el tratamiento de infecciones de mucosas.
EP3482743A1 (de) 2017-11-14 2019-05-15 ProFem GmbH Emulsionen zur behandlung von scheideninfektionen
EP3482744A1 (de) 2017-11-14 2019-05-15 ProFem GmbH Emulsionen zur topischen behandlung urogenitaler und dermaler infektionen
FR3089788B1 (fr) * 2018-12-17 2020-12-18 Lesaffre & Cie Souche de levure Saccharomyces cerevisiae pour le traitement et/ou la prévention de candidoses oropharyngées
WO2023220224A1 (en) * 2022-05-12 2023-11-16 St. Jude Children's Research Hospital, Inc. Synergistic antifungal composition and method
WO2024187210A1 (de) 2023-03-15 2024-09-19 Profem Gmbh Kombinationsarzneimittel zur behandlung und reduktion der rückfallraten vaginaler mykosen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6471823A (en) * 1987-09-12 1989-03-16 Rohto Pharma Sustained remedy for vaginal candidiasis
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
ES2079994B1 (es) 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
JPH09510185A (ja) * 1993-12-23 1997-10-14 ザ、プロクター、エンド、ギャンブル、カンパニー 組織モイスチャライジング及び抗菌組成物
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
US6159977A (en) 1998-11-16 2000-12-12 Astan, Inc. Therapeutic anti-fungal nail preparation
WO2000048633A1 (en) 1999-02-19 2000-08-24 Ligocyte Pharmaceuticals, Inc. Antibodies against hydrophobic proteins that are protective against candidiasis
DE60036800T2 (de) 1999-03-24 2008-07-24 Zengen Inc., Calabasas Antimikrobielle aminosäuresequenzen aus alpha-melanocyten-stimulierendem hormon
GB0108082D0 (en) 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
US20030181384A1 (en) 2001-09-06 2003-09-25 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
US20040142910A1 (en) * 2002-10-21 2004-07-22 Aegis Biosciences Llc Sulfonated styrene copolymers for medical uses
AU2003293529A1 (en) * 2002-12-16 2004-07-29 Nitromed, Inc. Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use
EP1637132B1 (en) * 2003-06-25 2010-10-06 Hisamitsu Pharmaceutical Co., Inc. External preparation for athlete´s foot treatment
WO2005009342A2 (en) 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
ES2237298B1 (es) * 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
WO2005117831A1 (en) 2004-05-28 2005-12-15 Schering Corporation Injectable pharmaceutical suspension comprising posaconazole

Also Published As

Publication number Publication date
EP2018164B1 (de) 2017-03-01
AU2007250502A1 (en) 2007-11-22
CA2651726A1 (en) 2007-11-22
US8552042B2 (en) 2013-10-08
RU2008148977A (ru) 2010-06-20
CY1119094T1 (el) 2018-01-10
WO2007131253A3 (de) 2008-11-27
US8815925B2 (en) 2014-08-26
NO345064B1 (no) 2020-09-14
EP2018164A2 (de) 2009-01-28
RS56044B1 (sr) 2017-09-29
NO342103B1 (no) 2018-03-26
NO20085181L (no) 2009-02-10
JP2009536926A (ja) 2009-10-22
WO2007131253A2 (de) 2007-11-22
AU2007250502B2 (en) 2013-11-28
EP3192507A1 (de) 2017-07-19
HUE033499T2 (en) 2017-12-28
PL2018164T3 (pl) 2017-08-31
ES2627268T3 (es) 2017-07-27
SI2018164T1 (sl) 2017-07-31
EP3192507B1 (de) 2020-07-08
DK2018164T3 (en) 2017-06-12
US20090208558A1 (en) 2009-08-20
US20140030312A1 (en) 2014-01-30
CN101484162A (zh) 2009-07-15
NO20180083A1 (no) 2009-02-10
CA2651726C (en) 2015-12-15
LT2018164T (lt) 2017-07-10
PT2018164T (pt) 2017-06-12

Similar Documents

Publication Publication Date Title
HRP20170793T1 (hr) Uporaba kombiniranih pripravaka koji obuhvaćaju antimikotike
ATE541572T1 (de) Tetrahydro-naphtalinderviate als glucocorticoidrezeptor-modulatoren
CO6220926A2 (es) Formulacion farmaceutica topica para la aplicacion de un farmaco antiinflamatorio no esferoidal (nsaid)
EP2144609A4 (en) PHARMACEUTICAL FORMULATIONS WITH LIPOSIC ACID DERIVATIVES
EP2174667A4 (en) AGENT FOR THE TREATMENT OF EYE IGNITIONS WITH INTERLEUKIN-6-RECEPTOR HEMMER AS AN ACTIVE SUBSTANCE
WO2007144327A3 (en) Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands
UY31419A1 (es) Nueva forma cristalina vi de la agomelatina, su procedimiento de preparacion y las composiciones farmacéuticas que la contienen
MY153620A (en) Novel sulphur containing lipids for use as food supplementor as medicament
CR10875A (es) Derivados de ester y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides
BRPI0620229B8 (pt) formulações farmaceuticas e processos de produção da ditas formulações
RU2011138101A (ru) Фармацевтическая композиция, проявляющая противовоспалительные свойства
UY30863A1 (es) Derivados de piridopirimidina, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones
WO2009125434A3 (en) Oxime derivatives, process for their preparation, pharmaceutical composition containing the same and medicinal use thereof
WO2008074834A3 (en) Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd)
WO2011006935A3 (en) Tetrazole derivatives
WO2008074832A3 (en) Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase ( scd)
WO2008012338A3 (en) Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions
FR2915683B1 (fr) Formulations pharmaceutiques auto-precipitantes pour la liberation modifiee de principe actif
UY29193A1 (es) Nuevas formulaciones de tabletas de liberación modificada para inhibidores de bomba de protón
HRP20161340T1 (hr) Formulacije darunavira
NO20071485L (no) Kjemiske substanser.
DE602005019509D1 (de) Verfahren für die zubereitung der amorphen form eines medikamentes
PH12014502609B1 (en) Multilayer coating form of orally administered pharmaceutical composition containing omega-3 fatty acid or alkyl ester thereof and statin based drug
MX369508B (es) Derivados de tio novedosos que tienen lactamas como potentes inhibidores de hdac y sus usos como medicamentos.
MX2014001065A (es) Formulaciones de (trimetoxifenilamino) pirimidilino nuevas.